🔥🐔 BizChicken 🐔🔥
Companies Similar to Seres Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Gain Therapeutics, Inc.
Site-Directed Enzyme Enhancement Therapy platform
Gain Therapeutics, Inc. is a biotechnology company developing therapies for diseases caused by protein misfolding, focusing on rare genetic diseases and neurological disorders. It utilizes its proprietary technology to discover and develop molecules targeting misfolded proteins.
Symbol: GANX
Recent Price: $2.18
Industry: Biotechnology
CEO: Mr. Gene Mack M.B.A.
Sector: Healthcare
Employees: 29
Address: 4800 Montgomery Lane, Bethesda, MD 20814
Phone: 301 500 1556
Last updated: 2024-12-31
Capricor Therapeutics, Inc.
CAP-1002
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing transformative cell and exosome-based therapeutics aimed at treating and preventing a range of diseases and disorders. Their lead candidate, CAP-1002, is designed for Duchenne muscular dystrophy and cytokine storm interventions.
About | Leadership | Directors | About | About | Contact | Careers | About | About | About | About
Symbol: CAPR
Recent Price: $13.76
Industry: Biotechnology
CEO: Dr. Linda Marbán Ph.D.
Sector: Healthcare
Employees: 101
Address: 10865 Road to the Cure, San Diego, CA 92121
Phone: 310 358 3200
Leadership
- Linda Marbán, Ph.D., Chief Executive Officer and Director
- Kristi A. H. Elliott, Ph.D., Chief Science Officer
- AJ Bergmann, M.B.A., Chief Financial Officer
- Karen G. Krasney, J.D., Executive Vice President and General Counsel
- Mark Awadalla, Vice President of Clinical Operations
- Jonathan Tayco, Vice President of Program Management and Business Operations
- Minghao Sun, Ph.D., Vice President of Research and Product Development
- Yushi Feng, Ph.D., Vice President of Regulatory Affairs
- Frank Litvack M.D., FACC, Executive Chairman
- Paul G. Auwaerter, M.D., M.B.A., FIDSA, Director
- Earl M. (Duke) Collier Jr., Director
- George W. Dunbar, Jr., Director
- Philip J. Gotwals, Ph.D., Director
- Michael Kelliher, Director
- David B. Musket, Director
- Karimah Es Sabar, Director
Last updated: 2024-12-31
Mersana Therapeutics, Inc.
XMT-1592
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing antibody drug conjugates (ADC) for treating cancer patients with unmet needs. It specializes in ADC products like XMT-1592 and has strategic partnerships for the advancement of its innovative therapeutics.
Vision/Values | About | Directors | About | About | About | About | Contact | Contact | About | Careers | About | Culture | Benefits | Careers | Careers | Careers | Jobs | Jobs | Management | Careers | About | About | About | About
Symbol: MRSN
Recent Price: $1.42
Industry: Biotechnology
CEO: Dr. Martin H. Huber M.D.
Sector: Healthcare
Employees: 123
Address: 840 Memorial Drive, Cambridge, MA 02139
Phone: 617 498 0020
Leadership
- David Mott, Chairman of the Board
- Lawrence Alleva, Retired Partner, PriceWaterhouseCoopers
- Willard H. Dere, MD, Professor Emeritus of Internal Medicine, University of Utah
- Allene M. Diaz, Independent Commercial Strategy and Portfolio Management Consultant, AMD Consulting
- Andrew Hack MD, PhD, Managing Director, Bain Capital Life Sciences
- Kristen M. Hege, MD, Retired Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, Bristol Myers Squibb Company
- Anna Protopapas, Chair of the board of directors of Nuvalent
- Martin Huber, MD, President and Chief Executive Officer
Last updated: 2024-12-31
Seres Therapeutics, Inc.
SER-109
Seres Therapeutics, Inc. is a microbiome therapeutics platform company focused on developing bacterial consortia that interact with host cells and tissues to treat diseases, including SER-109 for clostridium difficile infection.
Symbol: MCRB
Recent Price: $0.83
Industry: Biotechnology
CEO: Mr. Eric D. Shaff M.B.A.
Sector: Healthcare
Employees: 233
Address: 200 Sidney Street, Cambridge, MA 02139
Phone: 617 945 9626
Last updated: 2024-12-31
Spero Therapeutics, Inc.
Tebipenem pivoxil hydrobromide (HBr), SPR206, SPR720
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for multi-drug resistant bacterial infections and rare diseases in the United States.
About | Leadership | About | Contact | Careers | Management | About | About
Symbol: SPRO
Recent Price: $1.02
Industry: Biotechnology
CEO: Mr. Satyavrat Shukla C.F.A.
Sector: Healthcare
Employees: 46
Address: 675 Massachusetts Avenue, Cambridge, MA 02139
Phone: 857 242 1600
Leadership
- Sath Shukla, President and Chief Executive Officer
- Esther Rajavelu, Chief Financial Officer and Chief Business Officer
- Timothy Keutzer, Chief Operating Officer
- James P. Brady, Chief Human Resource Officer
- Ankit Mahadevia, MD, Chairperson
- Cynthia Smith, Compensation Committee Chair
- Frank E. Thomas, Audit Committee Chair
- Patrick Vink, MD, Nominating and Corporate Governance Chair
- Milind Deshpande, PhD, Nominating and Corporate Governance Committee Member, Audit Committee Member, and Development Committee Member
- Scott Jackson, Nominating and Corporate Governance Member and Audit Committee Member
- John C. Pottage, Jr., M.D., Development Committee Chair
- Kathleen Tregoning, Compensation Committee Member
Last updated: 2024-12-31
Sensei Biotherapeutics, Inc.
Immuno Phage platform
Sensei Biotherapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of immunotherapies for cancer, leveraging platforms such as Immuno Phage and Tumor Microenvironment Activated Biologics.
Symbol: SNSE
Recent Price: $0.48
Industry: Biotechnology
CEO: Mr. John K. Celebi M.B.A.
Sector: Healthcare
Employees: 28
Address: 451 D Street, Rockville, MD 02210
Phone: 240 243 8000
Last updated: 2024-12-31
Spyre Therapeutics, Inc.
antibody therapeutics
Spyre Therapeutics, Inc. is a biotechnology company focusing on antibody therapeutics for treating inflammatory bowel disease, using advanced engineering and precision medicine.
Symbol: SYRE
Recent Price: $22.54
Industry: Biotechnology
CEO: Dr. Cameron Turtle DPHIL, Ph.D.
Sector: Healthcare
Employees: 50
Address: 221 Crescent Street, Waltham, MA 02453
Phone: 617 651 5940
Last updated: 2024-12-31
Sarepta Therapeutics, Inc.
EXONDYS 51, VYONDYS 53, AMONDYS 45, SRP-5051, SRP-9001, SRP-9003
Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on developing RNA-targeted therapeutics and gene therapies for rare diseases, including treatments for Duchenne muscular dystrophy.
Contact | About | Leadership | About | About | About | Locations | About | About | About | About
Symbol: SRPT
Recent Price: $121.19
Industry: Biotechnology
CEO: Mr. Douglas S. Ingram Esq.
Sector: Healthcare
Employees: 1314
Address: 215 First Street, Cambridge, MA 02142
Phone: 617 274 4000
Leadership
- Douglas S. Ingram, President and Chief Executive Officer
- Bilal Arif, Executive Vice President, Chief Technical Operations Officer
- Diane Berry, PhD, Executive Vice President, Chief Global Policy & Advocacy Officer
- Ryan E. Brown, JD, Executive Vice President, Chief General Counsel
- Ian M. Estepan, Executive Vice President, Chief Financial Officer
- Dallan Murray, Executive Vice President, Chief Customer Officer
- Alison Nasisi, Executive Vice President, Chief People Officer
- Louise R. Rodino-Klapac, PhD, Executive Vice President, Head of R&D, Chief Scientific Officer
- Will Tilton, Senior Vice President, Head of Strategy, Chief of Staff
- M. Kathleen Behrens, PhD, Chairwoman
- Richard J. Barry,
- Kathryn Boor, PhD,
- Michael Chambers,
- Deirdre Connelly,
- Stephen L. Mayo, PhD,
- Claude Nicaise, MD,
- Hans Wigzell, MD, PhD,
- John C. Martin, PhD (In Memoriam),
- Annemieke Aartsma-Rus, PhD,
- Carsten Bönnemann, MD,
- Joy Cavagnaro, PhD, DABT, Fellow ATS,
- Kay Davies, PhD, DBE FMedSci FRS,
- Steven Gray, PhD,
- Angela J. Russell, DPhil,
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Cidara Therapeutics, Inc.
rezafungin acetate
Cidara Therapeutics, Inc. is a biotechnology company focused on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology. Their lead product candidate is rezafungin acetate, a novel echinocandin antifungal for treating invasive fungal infections.
Symbol: CDTX
Recent Price: $25.25
Industry: Biotechnology
CEO: Dr. Jeffrey L. Stein Ph.D.
Sector: Healthcare
Employees: 69
Address: 6310 Nancy Ridge Drive, San Diego, CA 92121
Phone: 858 752 6170
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Erasca, Inc.
ERAS-007, ERAS-601, ERAS-801
Erasca, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
News | About | About | Careers | Careers | About | Careers | About | About | About | About | About
Symbol: ERAS
Recent Price: $2.55
Industry: Biotechnology
CEO: Dr. Jonathan E. Lim M.D.
Sector: Healthcare
Employees: 126
Address: 10835 Road to the Cure, San Diego, CA 92121
Phone: 858 465 6511
Last updated: 2024-12-31
Keros Therapeutics, Inc.
KER-050
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for hematological and musculoskeletal disorders. Their lead product candidate, KER-050, targets cytopenias, including anemia and thrombocytopenia.
About | Management | Directors | Contact | About | Contact | Careers | Benefits | Careers | About | Benefits | About | Careers | Jobs | Careers | Careers | Careers
Symbol: KROS
Recent Price: $15.64
Industry: Biotechnology
CEO: Dr. Jasbir S. Seehra Ph.D.
Sector: Healthcare
Employees: 149
Address: 99 Hayden Avenue, Lexington, MA 02421
Phone: 617 314 6297
Leadership
- Jasbir Seehra, Ph.D., Board Member
- Keith Regnante, M.B.A., Chief Financial Officer
- Christopher Rovaldi, President, Chief Operating Officer
- Esther Cho, J.D., Senior Vice President, General Counsel
- John Oram, M.B.A., Senior Vice President, Program and Portfolio Management
- Robin Wagner, Senior Vice President, Human Resources
- Carl L. Gordon, Ph.D., C.F.A., Board Member
- Jean-Jacques Bienaimé, M.B.A., Lead Independent Director
- Nima Farzan, M.B.A., Board Member
- Mary Ann Gray, Ph.D., Board Member
- Tomer Kariv, J.D., Board Member
- Julius Knowles, M.B.A., Board Member
- Ran Nussbaum, Board Member
- Alpna Seth, Ph.D., Board Member
Last updated: 2024-12-31
Kymera Therapeutics, Inc.
novel small molecule therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system.
About | About | Leadership | Foundation | Contact | Culture | About | About | Leadership | Foundation | About | About | About | Culture | Culture | Culture | Culture | About | About
Symbol: KYMR
Recent Price: $39.32
Industry: Biotechnology
CEO: Dr. Nello Mainolfi M.D., Ph.D.
Sector: Healthcare
Employees: 184
Address: 200 Arsenal Yards Boulevard, Watertown, MA 02472
Phone: 857 285 5300
Leadership
- Nello Mainolfi, Ph.D., Founder, President & CEO
- Jeremy Chadwick, Ph.D., Chief Operating Officer
- Ellen Chiniara, JD, Chief Legal Officer and Corporate Secretary
- Jared Gollob, MD, Chief Medical Officer
- Bruce Jacobs, CFA, MBA, Chief Financial Officer
- Karen Weisbach, Head of People and Culture
- Juliet Williams, Ph.D., Head of Research
- Bruce Booth, DPhil, Chairman and Co-Founder
- Felix J. Baker, PhD, Lead Independent Director
- Jeff Albers, JD, MBA,
- Pamela Esposito, PhD,
- Gorjan Hrustanovic, PhD,
- John Maraganore, PhD,
- Leigh Morgan,
- Victor Sandor, MDCM,
- Elena Ridloff, CFA,
Last updated: 2024-12-31
Summit Therapeutics Inc.
ridinilazole
Summit Therapeutics Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to treat infectious diseases, with a lead product candidate called ridinilazole in Phase III clinical trials for Clostridioides difficile infection (CDI).
About | About | Leadership | Directors | About | About | Careers | About | News | About | About | About | About | ESG | About | About | About | About | About | About | Contact | About | About | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About | About | Contact
Symbol: SMMT
Recent Price: $17.89
Industry: Biotechnology
CEO: Mr. Robert W. Duggan
Sector: Healthcare
Employees: 105
Address: One Broadway, Cambridge, MA 02142
Phone: 617 514 7149
Leadership
- Bob Duggan, CEO & Chairman
- Dr. Maky Zanganeh, CEO & President
- Dave Gancarz, Chief Business & Strategy Officer
- Dr. Urte Gayko, Chief Regulatory, Quality & Pharmacovigilance Officer
- Dr. Fong Clow, Chief Biometrics Officer
- Shelley D Spray, Chief Education & Brand Officer
- Dr. Allen S. Yang, Chief Medical Officer
- Bhaskar Anand, Head of Finance and Chief Accounting Officer
- Dr. Betty Chang, Head of Research, Oncology & Inflammation
- Dr. Andy Dwyer, Head of CMC & Supply Chain
- Dr. Noam Frey, SVP, Global Medical Affairs
- Pawan Parihar, Head of Information Technology
- Dr. Juthamas Sukbuntherng, Head of Clinical Pharmacology & DMPK
- Robert W. Duggan, CEO & Chairman of the Board
- Dr. Mahkam (Maky) Zanganeh, CEO, President & Director
- Manmeet Soni, Chief Operating Officer, Chief Financial Officer & Director
- Kenneth A. Clark, Lead Independent Director
- Dr. Robert Booth, Non-Executive Director
- Dr. Alessandra Cesano, Non-Executive Director
- Dr. Yu (Michelle) Xia, Director
- Dr. Mostafa Ronaghi, Non-Executive Director
- Jeff Huber, Non-Executive Director
Last updated: 2024-12-31
Shattuck Labs, Inc.
SL-172154
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States, with its lead product candidate being SL-172154.
About | About | News | About | Contact | Culture | Leadership | Leadership
Symbol: STTK
Recent Price: $1.17
Industry: Biotechnology
CEO: Dr. Taylor H. Schreiber M.D., Ph.D.
Sector: Healthcare
Employees: 75
Address: 500 West 5th Street, Austin, TX 78703
Phone: 512 900 4690
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Theriva Biologics, Inc.
SYN-004, SYN-020, VCN-01
Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.
Symbol: TOVX
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Steven A. Shallcross CPA
Sector: Healthcare
Employees: 22
Address: 9605 Medical Center Drive, Rockville, MD 20850
Phone: 301 417 4364
Last updated: 2024-12-31
Finch Therapeutics Group, Inc.
CP101
Finch Therapeutics Group, Inc. is a clinical-stage microbiome therapeutics company developing a novel class of orally administered biological drugs, with a lead candidate CP101 in Phase 3 trials for recurrent Clostridioides difficile infection, and a pipeline for other conditions.
Symbol: FNCH
Recent Price: $10.87
Industry: Biotechnology
CEO: Mr. Matthew P. Blischak J.D.
Sector: Healthcare
Employees: 1
Address: 200 Inner Belt Road, Somerville, MA 02143
Phone: 617 229 6499
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31